BioHarvest Sciences Inc. Files November 2024 6-K Report

Ticker: BHST · Form: 6-K · Filed: Nov 8, 2024

Sentiment: neutral

Topics: 6-K, foreign-private-issuer, company-update

Related Tickers: BHSC

TL;DR

BHSC filed its monthly 6-K, standard foreign issuer report.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on November 8, 2024, reporting for the month of November 2024. The company, previously known as Midnight Star Ventures Corp. and Canna-V-Cell Sciences Inc., is incorporated in A1 and has its principal executive offices in Vancouver, British Columbia, Canada. This filing is a report of a foreign private issuer.

Why It Matters

This filing provides routine updates for investors and the market regarding BioHarvest Sciences Inc.'s status as a foreign private issuer.

Risk Assessment

Risk Level: low — This filing is a routine report for a foreign private issuer and does not contain significant new financial or operational information.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.

What is the filing date of this Form 6-K?

The filing date of this Form 6-K is November 8, 2024.

What is the reporting period for this Form 6-K?

The reporting period for this Form 6-K is the month of November 2024.

What were BioHarvest Sciences Inc.'s former company names?

BioHarvest Sciences Inc. was formerly known as Midnight Star Ventures Corp. and Canna-V-Cell Sciences Inc.

Where are BioHarvest Sciences Inc.'s principal executive offices located?

BioHarvest Sciences Inc.'s principal executive offices are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 16.5 · Accepted 2024-11-08 10:18:45

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: November 8, 2024 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations, & Secretary

View on Read The Filing